Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Chowdhury, S., Shore, N., Saad, F., Higano, C. S., Fizazi, K., Iversen, P., Miller, K., Heidenreich, A., Ueda, T., Kim, C. S., Phung, D., Krivoshik, A., Wang, F., Wu, K. and Tombal, B. (2016). Fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide: data from randomised clinical trials. Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Pozdnyakova, O., Rodig, S., Bhandarkar, S., Wu, K., Thiele, J. and Hasserjian, R. (2015). The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading. Leukemia, 29 (1). S. 241 - 246. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Pozdnyakova, O., Wu, K., Patki, A., Rodig, S. J., Thiele, J. and Hasserjian, R. (2014). High Concordance in Grading Reticulin Fibrosis and Hematopoietic Cellularity in Patients with Myeloproliferative Neoplasms Enrolled on Fedratinib (A JAK2 Inhibitor) Trials. Lab. Invest., 94. S. 371A - 373. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0307

Pozdnyakova, O., Wu, K., Patki, A., Rodig, S. J., Thiele, J. and Hasserjian, R. (2014). High Concordance in Grading Reticulin Fibrosis and Hematopoietic Cellularity in Patients with Myeloproliferative Neoplasms Enrolled on Fedratinib (A JAK2 Inhibitor) Trials. Mod. Pathol., 27. S. 371A - 373. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0285

This list was generated on Tue Apr 23 13:19:19 2024 CEST.